Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance.
van Roon AH, Wilschut JA, Hol L, van Ballegooijen M, Reijerink JC, 't Mannetje H, Kranenburg LJ, Biermann K, van Vuuren AJ, Francke J, van der Togt AC, Habbema DJ, van Leerdam ME, Kuipers EJ. van Roon AH, et al. Among authors: van der togt ac. Clin Gastroenterol Hepatol. 2011 Apr;9(4):333-9. doi: 10.1016/j.cgh.2010.12.012. Epub 2010 Dec 23. Clin Gastroenterol Hepatol. 2011. PMID: 21185397
Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.
van Roon AH, Hol L, van Vuuren AJ, Francke J, Ouwendijk M, Heijens A, Nagtzaam N, Reijerink JC, van der Togt AC, van Ballegooijen M, Kuipers EJ, van Leerdam ME. van Roon AH, et al. Among authors: van der togt ac. Am J Gastroenterol. 2012 Jan;107(1):99-107. doi: 10.1038/ajg.2011.396. Epub 2011 Nov 22. Am J Gastroenterol. 2012. PMID: 22108450
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.
Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME. Hol L, et al. Among authors: van der togt ac. Br J Cancer. 2009 Apr 7;100(7):1103-10. doi: 10.1038/sj.bjc.6604961. Br J Cancer. 2009. PMID: 19337257 Free PMC article. Clinical Trial.